| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 8 | 8 | 8 | 8 | 8 | 8 | 6 | 7 | 7 | 7 | 7 | 7 |
| Expenses | 7 | 8 | 8 | 8 | 7 | 7 | 6 | 6 | 7 | 7 | 6 | 6 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 6 % | 6 % | 5 % | 5 % | 5 % | 4 % | 5 % | 8 % | 9 % | 8 % | 8 % | 7 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| EPS in ₹ | 0.21 | 0.21 | 0.40 | 0.65 | 0.34 | -0.01 | 0.45 | 0.74 | 1.82 | 1.93 | 1.97 | 1.90 |
Colinz Laboratories
Colinz Laboratories
42.00
0.00
(0.00%)
Key Fundamentals
Market Cap
19.20 Cr
EPS
1.97
PE Ratio
40.00
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
88.70
52 Week Low
37.56
PB Ratio
1.67
Debt to Equity
0.07
Sector
Pharmaceuticals Actual
Company News
View All News
Colinz Laboratories has announced a postal ballot to seek shareholder approval for the sale of two key assets. The Board of Directors approved the proposal on October 14, 2025, to dispose of a pharmaceutical manufacturing factory in Sinnar, Nashik, and office premises in Mumbai, each valued at not less than Rs 3 crores. The factory sale is driven by the need for expensive modifications to comply with new WHO norms and deteriorating infrastructure from the 1995-1998 construction period. The Mumbai office premises, measuring 1088 sq feet across three units, face limitations due to aging facilities and nearby electric tower installations preventing redevelopment. Both assets represent more than 20% of the company's net worth or income, requiring special resolution approval. The e-voting period runs from October 15 to November 14, 2025, with a cut-off date of October 7, 2025. The company plans to use proceeds potentially for constructing a new WHO-compliant facility.
Colinz Laboratories' Board of Directors approved unaudited financial results for the quarter ended June 30, 2025, along with the Director's Report and other governance documents for the year ended March 31, 2025. The Board recommended the appointment of Mr. Swapnil Jayeshbhai Madiyar as Non-Promoter, Non-Executive Director effective September 30, 2025, and the reappointment of Mr. N. K. Menon as Whole Time Director and CEO for a one-year term from October 1, 2025 to September 30, 2026. Both appointments are subject to shareholder approval at the upcoming Annual General Meeting. The company scheduled its 39th Annual General Meeting for September 30, 2025, via video conference, with the register of members closing from September 23-30, 2025. The Board also appointed M/s. Sanjay Dholakia & Associates as Secretarial Auditor and CA Ajay Ramsevak Sharma as Internal Auditor for the financial year 2025-26.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,692.10 | #1 4,05,991.47 | 39.01 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 61.71 | |
6,600.00 | 1,75,209.26 | 75.90 | 9,712.00 | 18.67 | 2,191 | 26.74 | 72.60 | |
1,649.90 | 1,33,271.34 | 24.96 | 28,409.50 | 7.12 | 5,291 | 9.88 | 60.63 | |
3,620.00 | 1,22,517.25 | 60.69 | 11,539.40 | 6.99 | 1,911 | 19.91 | 53.74 | |
1,282.20 | 1,07,014.18 | #1 18.74 | 33,741.20 | 16.73 | 5,725 | 1.26 | 48.97 | |
1,009.00 | 1,01,529.01 | 21.36 | 23,511.00 | 18.55 | 4,615 | 2.60 | 45.37 | |
2,446.50 | 1,00,981.36 | 52.80 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 47.04 | |
1,949.80 | 89,058.00 | 23.85 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.82 | |
5,561.00 | 66,490.10 | 28.44 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.11 | |
1,104.40 | 64,143.73 | 19.03 | 32,345.60 | 9.43 | 3,484 | -10.24 | 50.87 |
Growth Rate
Revenue Growth
-6.85 %
Net Income Growth
-
Cash Flow Change
-240.78 %
ROE
-3.68 %
ROCE
-8.54 %
EBITDA Margin (Avg.)
3.75 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 | 11 | 12 |
| Fixed Assets | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Current Assets | 6 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 8 | 9 | 9 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 8 | 7 | 7 | 7 | 7 | 6 | 8 | 7 | 8 | 9 | 9 |
| Total Liabilities | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 | 11 | 12 |
| Current Liabilities | 2 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
| Non Current Liabilities | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 9 | 10 |
| Reserve & Surplus | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 6 | 6 | 7 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | -0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 1 | -2 |
| Investing Activities | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 |
| Operating Activities | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 1 | -2 |
| Financing Activities | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Apr 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 36.42 % | 36.42 % | 36.41 % | 36.41 % | 36.38 % | 66.01 % | 66.01 % | 65.93 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % | 66.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.07 % | 0.07 % | 0.00 % | 0.07 % | 0.07 % | 0.12 % | 0.12 % | 0.12 % | 0.12 % | 0.12 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 60.14 % | 59.76 % | 59.89 % | 59.83 % | 59.92 % | 31.83 % | 31.81 % | 31.84 % | 31.80 % | 31.88 % | 32.00 % | 31.51 % | 31.54 % | 31.09 % | 30.95 % | 31.04 % | 31.01 % | 30.44 % | 31.04 % | 30.97 % |
| Others | 3.38 % | 3.76 % | 3.70 % | 3.69 % | 3.64 % | 2.05 % | 2.07 % | 2.11 % | 2.07 % | 2.00 % | 2.00 % | 2.49 % | 2.45 % | 2.91 % | 3.05 % | 2.96 % | 2.99 % | 3.56 % | 2.95 % | 3.03 % |
| No of Share Holders | 0 | 2,146 | 2,279 | 2,421 | 2,607 | 2,821 | 2,639 | 2,646 | 2,794 | 2,863 | 2,825 | 2,873 | 2,915 | 2,929 | 2,980 | 3,116 | 3,202 | 3,216 | 3,238 | 3,272 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 63.22 | 58.00 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 54.99 | 57.52 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 59.95 | 57.93 |
| 16 May 2025 | Quarterly Result Announcement | NA | 16 May 2025 | 50.63 | 57.50 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 40.19 | 45.31 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 45.31 | 43.11 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
6 days ago
6 days agoDISCLOSURE UNDER REGULATION 30 AND 37A8 days ago
8 days agoPostal Ballot Notice8 days ago
8 days agoShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot8 days ago
8 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 11, 2025
Oct 11, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 04, 2025
Oct 04, 2025Non Applicability Under Regulation 32 Of SEBI (LODR) Regulation2015 For The Quarter Ended On 30-9-2025Oct 03, 2025
Oct 03, 2025Non-Applicability Of Related Party Transactions Under Regulation 23(9) For The 30Th Sep-2025Oct 03, 2025
Oct 03, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 30, 2025
Sep 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Reg. 34 (1) Annual Report.Aug 28, 2025
Aug 28, 2025BOOK CLOSURE FOR THE 39TH AGM OF M/S COLINZ LABORATORIES LTDAug 26, 2025
Aug 26, 202539Th AGM NOTICE AND BOOK CLOSUREAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Aug 01, 2025RESULTS FOR THE QUARTER ENDED ON 30-6-2025Jul 31, 2025
Jul 31, 2025Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 31-07-2025Jul 31, 2025
Jul 31, 2025Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015.Jul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue Rights Issue Preferential Issue QIP) For The Quarter Ended 30.06.2025.
Jul 02, 2025
Jul 02, 2025Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements Regulation 2015) For The Quarter Ended 30-6-2025.Jul 02, 2025
Jul 02, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
May 17, 2025Integrated Filing (Financial)May 16, 2025
May 16, 2025Board Meeting Outcome for Outcome Of The Board MeetingMay 16, 2025
May 16, 2025Outcome Of The Board MeetingMay 16, 2025
May 16, 2025Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015.May 07, 2025
May 07, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Confirmation Of Not Being Identified As Large Corporate In Terms Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018 - Fund Raising By Issuance Of Debt Securities By Large EntitiesApr 03, 2025
Apr 03, 2025Non - Applicability Of Annual Secretarial Compliance Report Under Regulation 24A Of SEBI (LODR) Regulations 2015 (As Amended) Read With SEBI Circular No. CIR/CFD/CMD1/27/2019 Dated 8Th February 2019 BSE Circular Nos. LIST/COMP/10/2019-20 Dated 9Th May 201Apr 03, 2025
Apr 03, 2025Annual Disclosure Of Encumberances Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011 For The Year Ended 31St March 2025Apr 03, 2025
Apr 03, 2025Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements Regulation 2015).Apr 02, 2025
Apr 02, 2025Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue Rights Issue Preferential Issue QIP) For The Quarter Ended 31.03.2025.
Apr 02, 2025
Apr 02, 2025Closure of Trading WindowMar 29, 2025
Mar 29, 2025Integrated Filing (Financial)Mar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2025
Feb 01, 2025Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015Jan 31, 2025
Jan 31, 2025Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015Jan 31, 2025
Jan 31, 2025Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015.Jan 13, 2025
Jan 13, 2025Pursuant To Regulation 13 (3) Of The SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015 The Statement Of Investor Complaints Of The Company For The Quarter Ended 31St December 2024Jan 08, 2025
Jan 08, 2025Intimation To Exchange Pursuant To Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015Jan 08, 2025
Jan 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements Regulation 2015).Jan 02, 2025
Jan 02, 2025Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue Rights Issue Preferential Issue QIP) For The Quarter EJan 02, 2025
Jan 02, 2025Closure of Trading WindowDec 31, 2024
Dec 31, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2024
Oct 31, 2024Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015Oct 30, 2024
Oct 30, 2024Technical Indicators
RSI(14)
Neutral 49.83
ATR(14)
Less Volatile 2.69
STOCH(9,6)
Neutral 46.69
STOCH RSI(14)
Neutral 33.98
MACD(12,26)
Bearish -0.07
ADX(14)
Weak Trend 19.52
UO(9)
Bearish 52.50
ROC(12)
Downtrend And Accelerating -4.00
WillR(14)
Neutral -45.45
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
